Exact Mass: 341.1142

Exact Mass Matches: 341.1142

Found 84 metabolites which its exact mass value is equals to given mass value 341.1142, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

protodeoxyviolaceinic acid

protodeoxyviolaceinic acid

C21H15N3O2 (341.1164)


A pyrrolecarboxylic acid that is pyrrole-2-carboxylic acid which is substituted at position 3 and 5 by indol-3-yl groups.

   

(2,5-Dihydroxypyrrol-1-yl) 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoate

(2,5-Dihydroxypyrrol-1-yl) 5-[(3as,4S,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-D]imidazol-4-yl]pentanoic acid

C14H19N3O5S (341.1045)


   

(2,5-Dioxopyrrolidin-1-yl) 5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoate

(2,5-Dioxopyrrolidin-1-yl) 5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-D]imidazol-4-yl)pentanoic acid

C14H19N3O5S (341.1045)


   

Nep-IN-2

2-({1-hydroxy-2-[(2-methylphenyl)methyl]-3-sulphanylpropylidene}amino)-4-(methylsulphanyl)butanoic acid

C16H23NO3S2 (341.1119)


   

3-Amino-N-[(4-methoxyphenyl)methyl]-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide

3-Amino-N-[(4-methoxyphenyl)methyl]-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide

C18H19N3O2S (341.1198)


   
   
   
   

hydracyanoside E

hydracyanoside E

C15H19NO8 (341.1111)


   

Trigonostemine E

Trigonostemine E

C21H15N3O2 (341.1164)


   

Trigonostemine F

Trigonostemine F

C21H15N3O2 (341.1164)


   

Trigonostemine A

Trigonostemine A

C21H15N3O2 (341.1164)


   
   
   

4-Demethyl-4-carboxy tolazamide

4-Demethyl-4-carboxy tolazamide

C14H19N3O5S (341.1045)


   

hydracyanoside A

hydracyanoside A

C15H19NO8 (341.1111)


   
   

bisindolylmaleimide v

n-methylbis(indol-3-yl)maleimide

C21H15N3O2 (341.1164)


Bisindolylmaleimide V is a cell-permeable negative control for protein kinase C inhibition studies with an IC50 value over 100 μM[1]. Bisindolylmaleimide V blocks the activation of mitogen-stimulated protein kinase p70s6k/p85s6k (S6K) in vivo with an IC50 of 8 μM[2].

   
   
   

1,N6-Benzoquinone-deoxyadenosine

1,N6-Benzoquinone-deoxyadenosine

C16H15N5O4 (341.1124)


   
   
   
   
   
   

Diethylpropion(metabolite VIII-glucuronide)

Diethylpropion(metabolite VIII-glucuronide)

C15H19NO8 (341.1111)


   
   

PC(2:0/2:0)

3,5,9-Trioxa-4-phosphaundecan-1-aminium, 7-(acetyloxy)-4-hydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide, (R)-

C12H24NO8P (341.1239)


   

PC(2:0/2:0)[S]

3,5,9-Trioxa-4-phosphaundecan-1-aminium, 7-(acetyloxy)-4-hydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide, (S)-

C12H24NO8P (341.1239)


   

Diacetyllecithin

1-acetyl-2-acetyl-sn-glycero-3-phosphocholine

C12H24NO8P (341.1239)


   

Ro 31-6045

3,4-di-1H-indol-3-yl-1-methyl-1H-pyrrole-2,5-dione

C21H15N3O2 (341.1164)


Bisindolylmaleimide V is a cell-permeable negative control for protein kinase C inhibition studies with an IC50 value over 100 μM[1]. Bisindolylmaleimide V blocks the activation of mitogen-stimulated protein kinase p70s6k/p85s6k (S6K) in vivo with an IC50 of 8 μM[2].

   

Biotin NHS

6aR-hexahydro-2-oxo-2,5-dioxo-1-pyrrolidinyl ester-1H-thieno[3aS,4-d]imidazole-4S-pentanoic acid

C14H19N3O5S (341.1045)


   

Lys-Ser-OH

(S)-2-(3-(4-aminobutoxy)-4-nitrobenzamido)-4-hydroxybutanoic acid

C14H19N3O7 (341.1223)


   

PC 4:0

1,2-diacetyl-sn-glycero-3-phosphocholine

C12H24NO8P (341.1239)


   

9-(1H-benzimidazol-2-ylsulfinyl)-4-methoxy-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridine

9-(1H-benzimidazol-2-ylsulfinyl)-4-methoxy-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridine

C18H19N3O2S (341.1198)


   

3-(benzenesulfonyl)-7-piperazin-1-yl-1H-indole

3-(benzenesulfonyl)-7-piperazin-1-yl-1H-indole

C18H19N3O2S (341.1198)


   

1-(benzenesulfonyl)-4-piperazin-1-ylindole

1-(benzenesulfonyl)-4-piperazin-1-ylindole

C18H19N3O2S (341.1198)


   

N-methyl-1-(5-phenyl-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methanamine

N-methyl-1-(5-phenyl-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methanamine

C18H19N3O2S (341.1198)


   

1-(2-PYRROLIDINOETHYL)PIPERAZINE

1-(2-PYRROLIDINOETHYL)PIPERAZINE

C18H19N3O2S (341.1198)


   

1-(2-PYRROL-1-YL-ETHYL)PIPERAZINE

1-(2-PYRROL-1-YL-ETHYL)PIPERAZINE

C18H19N3O2S (341.1198)


   

4-TRIMETHYLAMMONIUM-2,2,6,6-TETRAMETHYLPIPERIDINE-1-OXYL IODIDE

4-TRIMETHYLAMMONIUM-2,2,6,6-TETRAMETHYLPIPERIDINE-1-OXYL IODIDE

C12H26IN2O (341.109)


   

Benzenesulfonamide,N-ethyl-4-methyl-N-(5-phenyl-2-furanyl)-

Benzenesulfonamide,N-ethyl-4-methyl-N-(5-phenyl-2-furanyl)-

C19H19NO3S (341.1086)


   

VU0152100

3-Amino-N-[(4-methoxyphenyl)methyl]-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide

C18H19N3O2S (341.1198)


VU0152100 (VU152100) is a highly selective mAChR positive allosteric modulator (permeable to the blood-brain barrier). VU0152100 reverses Amphetamine-induced hypermotility in rats and increased levels of extracellular dopamine in nucleus accumbens and caudate-putamen. VU0152100 has good research potential in psychosis and cognitive impairment associated with mental disorders such as schizophrenia[1][2].

   

3-amino-2-nitro-1-phenyl-9,10-dihydrophenanthrene-4-carbonitrile

3-amino-2-nitro-1-phenyl-9,10-dihydrophenanthrene-4-carbonitrile

C21H15N3O2 (341.1164)


   

methyl (2S,3S,4S,5R,6S)-6-(4-acetamidophenoxy)-3,4,5-trihydroxyoxane-2-carboxylate

methyl (2S,3S,4S,5R,6S)-6-(4-acetamidophenoxy)-3,4,5-trihydroxyoxane-2-carboxylate

C15H19NO8 (341.1111)


   

6-(4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL)-5-CHLORONICOTINIC ACID

6-(4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL)-5-CHLORONICOTINIC ACID

C15H20ClN3O4 (341.1142)


   

2,5-Dioxopyrrolidin-1-yl 5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoate

2,5-Dioxopyrrolidin-1-yl 5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoate

C14H19N3O5S (341.1045)


   

4-[1-(4-fluorophenyl)-2-nitroethyl]-5-methyl-2-phenyl-1H-pyrazol-3-one

4-[1-(4-fluorophenyl)-2-nitroethyl]-5-methyl-2-phenyl-1H-pyrazol-3-one

C18H16FN3O3 (341.1176)


   

3,5-Dimethyl-4-[(4-methylphenyl)sulfonyl-phenylmethyl]isoxazole

3,5-Dimethyl-4-[(4-methylphenyl)sulfonyl-phenylmethyl]isoxazole

C19H19NO3S (341.1086)


   

L-Cysteinylglycyl-L-tyrosine

L-Cysteinylglycyl-L-tyrosine

C14H19N3O5S (341.1045)


   

2,3-Diacetyloxypropyl 2-(trimethylazaniumyl)ethyl phosphate

2,3-Diacetyloxypropyl 2-(trimethylazaniumyl)ethyl phosphate

C12H24NO8P (341.1239)


   

1-Hydroxy-2,2,5,5-tetramethyl-3-(methylsulfonylsulfanylmethyl)-4-phenylpyrrole

1-Hydroxy-2,2,5,5-tetramethyl-3-(methylsulfonylsulfanylmethyl)-4-phenylpyrrole

C16H23NO3S2 (341.1119)


   

N-(6-Aminohexyl)-1-chloro-naphthalene-5-sulfonamide

N-(6-Aminohexyl)-1-chloro-naphthalene-5-sulfonamide

C16H22ClN2O2S+ (341.109)


   

1-(3,5-Dimethylphenyl)-3-(4-methyl-3-oxo-1,4-benzothiazin-6-yl)urea

1-(3,5-Dimethylphenyl)-3-(4-methyl-3-oxo-1,4-benzothiazin-6-yl)urea

C18H19N3O2S (341.1198)


   

N-(2-furanylmethyl)-4-methyl-N-(phenylmethyl)benzenesulfonamide

N-(2-furanylmethyl)-4-methyl-N-(phenylmethyl)benzenesulfonamide

C19H19NO3S (341.1086)


   

[4-(2-Methylphenyl)-1-piperazinyl]-(4-nitrophenyl)methanethione

[4-(2-Methylphenyl)-1-piperazinyl]-(4-nitrophenyl)methanethione

C18H19N3O2S (341.1198)


   

2-[(3-cyano-8-methyl-2-quinolinyl)thio]-N-(2-oxolanylmethyl)acetamide

2-[(3-cyano-8-methyl-2-quinolinyl)thio]-N-(2-oxolanylmethyl)acetamide

C18H19N3O2S (341.1198)


   
   
   
   
   
   

INDOLE-1-ACETIC ACID, 3-(p-FLUOROBENZOYL)-6-METHOXY-2-METHYL-

INDOLE-1-ACETIC ACID, 3-(p-FLUOROBENZOYL)-6-METHOXY-2-METHYL-

C19H16FNO4 (341.1063)


   

Lnape 3:0/N-4:0

Lnape 3:0/N-4:0

C12H24NO8P (341.1239)


   

Lnape 2:0/N-5:0

Lnape 2:0/N-5:0

C12H24NO8P (341.1239)


   

Lnape 5:0/N-2:0

Lnape 5:0/N-2:0

C12H24NO8P (341.1239)


   

Lnape 4:0/N-3:0

Lnape 4:0/N-3:0

C12H24NO8P (341.1239)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] butanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] butanoate

C12H24NO8P (341.1239)


   

[1-Acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] pentanoate

[1-Acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] pentanoate

C12H24NO8P (341.1239)


   

1,2-diacetyl-sn-glycero-3-phosphocholine

1,2-diacetyl-sn-glycero-3-phosphocholine

C12H24NO8P (341.1239)


   
   
   
   

1-(7-methoxyquinolin-4-yl)-9h-pyrido[3,4-b]indol-3-ol

1-(7-methoxyquinolin-4-yl)-9h-pyrido[3,4-b]indol-3-ol

C21H15N3O2 (341.1164)


   

2-(2-hydroxy-4-methoxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)acetonitrile

2-(2-hydroxy-4-methoxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)acetonitrile

C15H19NO8 (341.1111)


   

(2r)-2-(3-hydroxy-4-methoxyphenyl)-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}acetonitrile

(2r)-2-(3-hydroxy-4-methoxyphenyl)-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}acetonitrile

C15H19NO8 (341.1111)


   

2-(3-hydroxy-4-methoxyphenyl)-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}acetonitrile

2-(3-hydroxy-4-methoxyphenyl)-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}acetonitrile

C15H19NO8 (341.1111)


   

5-{[4-(2h-1,3-benzodioxol-5-ylmethyl)-1-methylimidazol-2-yl]imino}-2-hydroxy-3-methylimidazol-4-one

5-{[4-(2h-1,3-benzodioxol-5-ylmethyl)-1-methylimidazol-2-yl]imino}-2-hydroxy-3-methylimidazol-4-one

C16H15N5O4 (341.1124)


   

(3s,6z)-3-[2-hydroxy-2-(c-hydroxycarbonimidoylimino)ethyl]-6-(1h-indol-3-ylmethylidene)-3h-pyrazine-2,5-diol

(3s,6z)-3-[2-hydroxy-2-(c-hydroxycarbonimidoylimino)ethyl]-6-(1h-indol-3-ylmethylidene)-3h-pyrazine-2,5-diol

C16H15N5O4 (341.1124)


   

3-{7-methoxy-9h-pyrido[3,4-b]indole-1-carbonyl}-1h-indole

3-{7-methoxy-9h-pyrido[3,4-b]indole-1-carbonyl}-1h-indole

C21H15N3O2 (341.1164)


   

2-(2-hydroxy-4-methoxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)acetonitrile

2-(2-hydroxy-4-methoxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)acetonitrile

C15H19NO8 (341.1111)


   

7-methoxy-1-(quinolin-4-yl)-9h-pyrido[3,4-b]indol-3-ol

7-methoxy-1-(quinolin-4-yl)-9h-pyrido[3,4-b]indol-3-ol

C21H15N3O2 (341.1164)